ID   KAP1_HUMAN              Reviewed;         381 AA.
AC   P31321; Q8N422;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 4.
DT   10-MAY-2017, entry version 167.
DE   RecName: Full=cAMP-dependent protein kinase type I-beta regulatory subunit;
GN   Name=PRKAR1B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CLEAVAGE OF INITIATOR METHIONINE.
RX   PubMed=1708242; DOI=10.1016/0006-291X(91)90904-L;
RA   Solberg R., Tasken K., Keiserud A., Jahnsen T.;
RT   "Molecular cloning, cDNA structure and tissue-specific expression of
RT   the human regulatory subunit RI beta of cAMP-dependent protein
RT   kinases.";
RL   Biochem. Biophys. Res. Commun. 176:166-172(1991).
RN   [2]
RP   SEQUENCE REVISION TO 98-100.
RC   TISSUE=Testis;
RX   PubMed=7925653; DOI=10.1006/excr.1994.1297;
RA   Solberg R., Tasken K., Wen W., Coghlan V.M., Meinkoth J.L.,
RA   Scott J.D., Jahnsen T., Taylor S.S.;
RT   "Human regulatory subunit RI beta of cAMP-dependent protein kinases:
RT   expression, holoenzyme formation and microinjection into living
RT   cells.";
RL   Exp. Cell Res. 214:595-605(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala, and Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NITRATION [LARGE SCALE ANALYSIS] AT TYR-21, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Pituitary adenoma;
RX   PubMed=16777052; DOI=10.1016/j.ab.2006.05.024;
RA   Zhan X., Desiderio D.M.;
RT   "Nitroproteins from a human pituitary adenoma tissue discovered with a
RT   nitrotyrosine affinity column and tandem mass spectrometry.";
RL   Anal. Biochem. 354:279-289(2006).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77 AND SER-83, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH PRKX.
RX   PubMed=20819953; DOI=10.1074/jbc.M110.155150;
RA   Diskar M., Zenn H.M., Kaupisch A., Kaufholz M., Brockmeyer S.,
RA   Sohmen D., Berrera M., Zaccolo M., Boshart M., Herberg F.W., Prinz A.;
RT   "Regulation of cAMP-dependent protein kinases: the human protein
RT   kinase X (PrKX) reveals the role of the catalytic subunit alphaH-
RT   alphaI loop.";
RL   J. Biol. Chem. 285:35910-35918(2010).
RN   [10]
RP   INTERACTION WITH C2ORF88/SMAKAP, AND SUBCELLULAR LOCATION.
RX   PubMed=23115245; DOI=10.1074/jbc.M112.395970;
RA   Burgers P.P., Ma Y., Margarucci L., Mackey M., van der Heyden M.A.,
RA   Ellisman M., Scholten A., Taylor S.S., Heck A.J.;
RT   "A small novel A-kinase anchoring protein (AKAP) that localizes
RT   specifically protein kinase A-regulatory subunit I (PKA-RI) to the
RT   plasma membrane.";
RL   J. Biol. Chem. 287:43789-43797(2012).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3 AND SER-83, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Regulatory subunit of the cAMP-dependent protein kinases
CC       involved in cAMP signaling in cells.
CC       {ECO:0000269|PubMed:20819953}.
CC   -!- SUBUNIT: The inactive holoenzyme is composed of two regulatory
CC       chains and two catalytic chains. Activation by cAMP releases the
CC       two active catalytic monomers and the regulatory dimer. Interacts
CC       with PRKX; regulates this cAMP-dependent protein kinase. Interacts
CC       with C2orf88/smAKAP; this interaction may target PRKAR1B to the
CC       plasma membrane. {ECO:0000269|PubMed:20819953,
CC       ECO:0000269|PubMed:23115245}.
CC   -!- INTERACTION:
CC       P17612:PRKACA; NbExp=4; IntAct=EBI-2805516, EBI-476586;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23115245}.
CC   -!- TISSUE SPECIFICITY: Four types of regulatory chains are found: I-
CC       alpha, I-beta, II-alpha, and II-beta. Their expression varies
CC       among tissues and is in some cases constitutive and in others
CC       inducible.
CC   -!- PTM: The pseudophosphorylation site binds to the substrate-binding
CC       region of the catalytic chain, resulting in the inhibition of its
CC       activity.
CC   -!- SIMILARITY: Belongs to the cAMP-dependent kinase regulatory chain
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M65066; AAC37564.1; -; mRNA.
DR   EMBL; AK315951; BAH14322.1; -; mRNA.
DR   EMBL; AK315990; BAH14361.1; -; mRNA.
DR   EMBL; BC026734; AAH26734.1; -; mRNA.
DR   EMBL; BC036828; AAH36828.2; -; mRNA.
DR   CCDS; CCDS34579.1; -.
DR   PIR; JH0392; OKHUR1.
DR   RefSeq; NP_001158230.1; NM_001164758.1.
DR   RefSeq; NP_001158231.1; NM_001164759.1.
DR   RefSeq; NP_001158232.1; NM_001164760.1.
DR   RefSeq; NP_001158233.1; NM_001164761.1.
DR   RefSeq; NP_001158234.1; NM_001164762.1.
DR   RefSeq; NP_002726.1; NM_002735.2.
DR   UniGene; Hs.520851; -.
DR   PDB; 4DIN; X-ray; 3.70 A; B=1-381.
DR   PDB; 4F9K; X-ray; 2.80 A; A/B/C/D=11-73.
DR   PDBsum; 4DIN; -.
DR   PDBsum; 4F9K; -.
DR   ProteinModelPortal; P31321; -.
DR   SMR; P31321; -.
DR   BioGrid; 111561; 34.
DR   IntAct; P31321; 75.
DR   MINT; MINT-240609; -.
DR   STRING; 9606.ENSP00000353415; -.
DR   GuidetoPHARMACOLOGY; 1473; -.
DR   iPTMnet; P31321; -.
DR   PhosphoSitePlus; P31321; -.
DR   BioMuta; PRKAR1B; -.
DR   DMDM; 229463042; -.
DR   EPD; P31321; -.
DR   MaxQB; P31321; -.
DR   PaxDb; P31321; -.
DR   PeptideAtlas; P31321; -.
DR   PRIDE; P31321; -.
DR   DNASU; 5575; -.
DR   Ensembl; ENST00000360274; ENSP00000353415; ENSG00000188191.
DR   Ensembl; ENST00000403562; ENSP00000385349; ENSG00000188191.
DR   Ensembl; ENST00000406797; ENSP00000385749; ENSG00000188191.
DR   Ensembl; ENST00000537384; ENSP00000440449; ENSG00000188191.
DR   Ensembl; ENST00000544935; ENSP00000444487; ENSG00000188191.
DR   GeneID; 5575; -.
DR   KEGG; hsa:5575; -.
DR   UCSC; uc003siu.3; human.
DR   CTD; 5575; -.
DR   DisGeNET; 5575; -.
DR   GeneCards; PRKAR1B; -.
DR   HGNC; HGNC:9390; PRKAR1B.
DR   HPA; HPA026719; -.
DR   MalaCards; PRKAR1B; -.
DR   MIM; 176911; gene.
DR   neXtProt; NX_P31321; -.
DR   OpenTargets; ENSG00000188191; -.
DR   PharmGKB; PA33756; -.
DR   eggNOG; KOG1113; Eukaryota.
DR   eggNOG; COG0664; LUCA.
DR   GeneTree; ENSGT00530000062947; -.
DR   HOGENOM; HOG000196669; -.
DR   HOVERGEN; HBG002025; -.
DR   InParanoid; P31321; -.
DR   KO; K04739; -.
DR   OMA; DQWERAN; -.
DR   OrthoDB; EOG091G0F1K; -.
DR   PhylomeDB; P31321; -.
DR   TreeFam; TF314920; -.
DR   Reactome; R-HSA-163615; PKA activation.
DR   Reactome; R-HSA-164378; PKA activation in glucagon signalling.
DR   Reactome; R-HSA-180024; DARPP-32 events.
DR   Reactome; R-HSA-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   Reactome; R-HSA-432040; Vasopressin regulates renal water homeostasis via Aquaporins.
DR   Reactome; R-HSA-5610787; Hedgehog 'off' state.
DR   Reactome; R-HSA-983231; Factors involved in megakaryocyte development and platelet production.
DR   ChiTaRS; PRKAR1B; human.
DR   GeneWiki; PRKAR1B; -.
DR   GenomeRNAi; 5575; -.
DR   PRO; PR:P31321; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000188191; -.
DR   CleanEx; HS_PRKAR1B; -.
DR   ExpressionAtlas; P31321; baseline and differential.
DR   Genevisible; P31321; HS.
DR   GO; GO:0005952; C:cAMP-dependent protein kinase complex; NAS:UniProtKB.
DR   GO; GO:0097546; C:ciliary base; TAS:Reactome.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004862; F:cAMP-dependent protein kinase inhibitor activity; IDA:BHF-UCL.
DR   GO; GO:0008603; F:cAMP-dependent protein kinase regulator activity; IDA:BHF-UCL.
DR   GO; GO:0034236; F:protein kinase A catalytic subunit binding; IPI:BHF-UCL.
DR   GO; GO:0034199; P:activation of protein kinase A activity; TAS:Reactome.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome.
DR   GO; GO:0007611; P:learning or memory; IEA:Ensembl.
DR   GO; GO:2000480; P:negative regulation of cAMP-dependent protein kinase activity; IDA:BHF-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; NAS:UniProtKB.
DR   GO; GO:0003091; P:renal water homeostasis; TAS:Reactome.
DR   Gene3D; 2.60.120.10; -; 2.
DR   InterPro; IPR012198; cAMP_dep_PK_reg_su.
DR   InterPro; IPR003117; cAMP_dep_PK_reg_su_I/II_a/b.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 2.
DR   Pfam; PF02197; RIIa; 1.
DR   PIRSF; PIRSF000548; PK_regulatory; 1.
DR   SMART; SM00100; cNMP; 2.
DR   SMART; SM00394; RIIa; 1.
DR   SUPFAM; SSF47391; SSF47391; 1.
DR   SUPFAM; SSF51206; SSF51206; 2.
DR   PROSITE; PS00888; CNMP_BINDING_1; 2.
DR   PROSITE; PS00889; CNMP_BINDING_2; 2.
DR   PROSITE; PS50042; CNMP_BINDING_3; 2.
PE   1: Evidence at protein level;
KW   3D-structure; cAMP; cAMP-binding; Cell membrane; Complete proteome;
KW   Disulfide bond; Membrane; Methylation; Nitration; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Repeat.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:1708242}.
FT   CHAIN         2    381       cAMP-dependent protein kinase type I-beta
FT                                regulatory subunit.
FT                                /FTId=PRO_0000205381.
FT   NP_BIND     137    254       cAMP 1.
FT   NP_BIND     255    381       cAMP 2.
FT   REGION        2    136       Dimerization and phosphorylation.
FT   MOTIF        96    100       Pseudophosphorylation motif.
FT   BINDING     202    202       cAMP 1.
FT   BINDING     211    211       cAMP 1.
FT   BINDING     326    326       cAMP 2.
FT   BINDING     335    335       cAMP 2.
FT   MOD_RES       3      3       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      21     21       Nitrated tyrosine.
FT                                {ECO:0000244|PubMed:16777052}.
FT   MOD_RES      77     77       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES      83     83       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES      85     85       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P12849}.
FT   MOD_RES      97     97       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:P12849}.
FT   DISULFID     18     18       Interchain (with C-39). {ECO:0000250}.
FT   DISULFID     39     39       Interchain (with C-18). {ECO:0000250}.
FT   CONFLICT    270    270       A -> R (in Ref. 1; AAC37564).
FT                                {ECO:0000305}.
FT   HELIX        19     24       {ECO:0000244|PDB:4F9K}.
FT   TURN         27     31       {ECO:0000244|PDB:4F9K}.
FT   HELIX        32     41       {ECO:0000244|PDB:4F9K}.
FT   HELIX        46     68       {ECO:0000244|PDB:4F9K}.
SQ   SEQUENCE   381 AA;  43073 MW;  1ED7BFEC30897191 CRC64;
     MASPPACPSE EDESLKGCEL YVQLHGIQQV LKDCIVHLCI SKPERPMKFL REHFEKLEKE
     ENRQILARQK SNSQSDSHDE EVSPTPPNPV VKARRRRGGV SAEVYTEEDA VSYVRKVIPK
     DYKTMTALAK AISKNVLFAH LDDNERSDIF DAMFPVTHIA GETVIQQGNE GDNFYVVDQG
     EVDVYVNGEW VTNISEGGSF GELALIYGTP RAATVKAKTD LKLWGIDRDS YRRILMGSTL
     RKRKMYEEFL SKVSILESLE KWERLTVADA LEPVQFEDGE KIVVQGEPGD DFYIITEGTA
     SVLQRRSPNE EYVEVGRLGP SDYFGEIALL LNRPRAATVV ARGPLKCVKL DRPRFERVLG
     PCSEILKRNI QRYNSFISLT V
//
